Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BV.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BV.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BV.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GA.4.1.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GA.4.1.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.4.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GS.7.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GS.7.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GS.7.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XWNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XWNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XWNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.1.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.1.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.1.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
KG.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
KG.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
KG.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDJNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDJNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDJNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.3.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.3.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.3.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.1.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.1.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.1.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.36.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.1.36.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.36.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.86.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.86.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.86.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDFNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XDFNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDFNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.575.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.575.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.575.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.12NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
JN.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.12NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used